The Interaction of Histamine H 3 and Dopamine D 1 Receptors on Hyperkinetic Alterations in Animal Models of Parkinson's Disease

Parkinson's disease is associated with the loss of more than 40% of dopaminergic neurons in the substantia nigra pars compacta. One of the therapeutic options for restoring striatal dopamine levels is the administration of L-3,4-dihydroxyphenylalanine (L-Dopa). However, Parkinson's disease...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pharmaceuticals (Basel, Switzerland) Switzerland), 2024-12, Vol.17 (12)
Hauptverfasser:	Avila-Luna, Alberto, Verduzco-Mendoza, Antonio, Olmos-Hernández, Adriana, Cortes-Altamirano, José Luis, Alfaro-Rodríguez, Alfonso, Arias-Montaño, José-Antonio, Bueno-Nava, Antonio
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!